Japanese companies must focus on R&D due to the weaknesses of their mature portfolios

January 14 2004--Dominated by domestic companies in the past, the Japanese pharmaceutical market is evolving, as regulatory changes stimulate increased competition from western companies and government cost containment measures restrict market growth. The Japanese pharmaceutical companies must focus on building strong pipelines in order to drive both domestic and overseas growth.

Scope

Benchmarking of leading players across a range of strategic, portfolio and financial measures, supported by an interactive Excel-based comparator tool

Profiles 17 Japanese pharma companies, providing analysis of the company's strategy, portfolio and pipeline and 6 year forecasts for key products

Evaluation of the strategic options available for Japanese pharmas to drive domestic and overseas expansion

Assessment of the strategies used by western big pharma to increase penetration of the Japanese market

Report Highlights

Japanese companies must focus on R&D due to the weaknesses of their mature portfolios. In 2002, 71.3% of the leading Japanese companies revenues came from drugs that are more than 10 years old

Overseas companies must consider their therapeutic focus and marketing capabilities to choose the best Japanese expansion strategy. Although recent changes have made it possible, and indeed far easier for western companies to launch their own products in Japan, many still choose to either out-license products or to co-promote/co-market them

Fujisawa is forecast to be the best performing Japanese company to 2008, reaping the rewards of its extensive alliance network, which included 20 new corporate agreements from January 2000 to October 2003. Other companies should look to follow suit if they are to successfully drive future growth

This report is useful as:

Benchmark your performance against the leading Japanese pharmas

Identify the best product sourcing strategy for your company's position

Optimize your Japanese market growth strategy through detailed knowledge of the performance of the Japanese pharmas, and local operating conditions


For a complete index of this report click on http://www.researchandmarkets.com/reports/41999

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com




This article courtesy of http://www.bonsai-hr.com.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Submit Your Article